EW
Edwards Lifesciences CorpCompany Information
- Company Name
- Edwards Lifesciences Corp
- CIK
- CIK0001099800
- Category
- Large accelerated filer
- Ticker: Exchange
- EW: NYSE
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3842
- SIC Description
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- Ticker
- EW
SEC filing data through
Insider Sentiment
- Last purchase
- 2024-05-06
- Last sale
- 2026-09-11
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 301,058.51
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 513,233,334
- Shares outstanding
- 576,400,000
- Ownership
- 89.04%
Earnings Market Reaction
- Filing date
- 2026-08-04
- Price on filing date
- —
- 1-month reaction
- 0.68%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 2,907 | 2,446 | 2,938 | 2,686 | 3,273 | 3,141 | 3,045 | 3,676 | 1,645 | 1,225 | 1,132 | 1,410 | ||||||
| Short Term Investments | 1,346 | 1,226 | 1,288 | 1,156 | 789 | 758 | 931 | 770 | 345 | 473 | 501 | 454 | ||||||
| Accounts Receivable Net Current | 770 | 776 | 660 | 693 | 697 | 669 | 609 | 716 | 778 | 818 | 772 | 740 | ||||||
| Other Receivables Net Current | 185 | 197 | 253 | 200 | 206 | 83 | 118 | 96 | 56 | 59 | 57 | - | ||||||
| Other Receivables | - | - | - | - | - | - | - | - | - | - | 62 | 62 | ||||||
| Inventory Net | 1,131 | 1,119 | 1,126 | 1,141 | 1,142 | 1,114 | 1,087 | 1,104 | 1,025 | 1,207 | 904 | 1,032 | ||||||
| Prepaid Expense Current | 119 | 136 | 135 | 125 | 110 | 111 | 121 | 115 | 110 | 138 | 129 | 133 | ||||||
| Other Assets Current | 360 | 330 | 339 | 323 | 314 | 305 | 348 | 231 | 252 | 251 | 225 | 236 | ||||||
| Assets Of Disposal Group Including Discontinued Operation Current | - | - | 0 | 35 | 46 | 33 | 27 | 20 | 305 | - | 318 | - | ||||||
| Assets Current | 6,819 | 6,229 | 6,739 | 6,359 | 6,577 | 6,213 | 6,285 | 6,728 | 4,516 | 4,171 | 4,036 | 4,068 | ||||||
| Long Term Investments | 244 | 286 | 279 | 275 | 299 | 278 | 308 | 320 | 353 | 456 | 584 | 705 | ||||||
| Property Plant And Equipment Net | 1,842 | 1,823 | 1,812 | 1,743 | 1,727 | 1,698 | 1,686 | 1,676 | 1,640 | 1,768 | 1,591 | 1,681 | ||||||
| Operating Lease Right Of Use Asset | 100 | 99 | 103 | 97 | 99 | 97 | 98 | 104 | 93 | 98 | 84 | 91 | ||||||
| Goodwill | 1,951 | 1,820 | 1,769 | 1,769 | 1,777 | 1,779 | 1,777 | 1,605 | 1,151 | 1,253 | 1,145 | 1,297 | ||||||
| Intangible Assets Net Excluding Goodwill | 1,383 | 1,228 | 1,128 | 1,131 | 1,173 | 1,175 | 1,177 | 956 | 417 | 447 | 399 | 430 | ||||||
| Deferred Income Tax Assets Net | 912 | 1,098 | 1,138 | 1,100 | 1,082 | 1,028 | 992 | 888 | 833 | 777 | 749 | 652 | ||||||
| Other Assets Noncurrent | 616 | 739 | 730 | 785 | 743 | 743 | 722 | 684 | 790 | 768 | 463 | 447 | ||||||
| Disposal Group Including Discontinued Operation Assets Noncurrent | - | - | 0 | 15 | 13 | 12 | 11 | 11 | 307 | - | 311 | - | ||||||
| Assets | 13,867 | 13,321 | 13,697 | 13,272 | 13,489 | 13,022 | 13,055 | 12,971 | 10,099 | 9,736 | 9,363 | 9,371 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 211 | 181 | 228 | 165 | 162 | 172 | 197 | 173 | 186 | 212 | 187 | 191 | ||||||
| Operating Lease Liability Current | 24 | 24 | 25 | 27 | 26 | 24 | 23 | 24 | 22 | 25 | 23 | 24 | ||||||
| Liabilities Of Disposal Group Including Discontinued Operation Current | - | - | 0 | 2 | 2 | 2 | 2 | 2 | 107 | - | 130 | - | ||||||
| Liabilities Current | 1,508 | 1,409 | 1,814 | 1,588 | 1,405 | 1,395 | 1,505 | 1,944 | 1,217 | 1,111 | 1,195 | 1,239 | ||||||
| Long Term Debt Noncurrent | 599 | 599 | 598 | 598 | 598 | 598 | 598 | 598 | 597 | 597 | 597 | 597 | ||||||
| Operating Lease Liability Noncurrent | 82 | 80 | 83 | 75 | 79 | 78 | 79 | 85 | 74 | 77 | 65 | 70 | ||||||
| Business Combination Contingent Consideration Liability Noncurrent | - | - | - | - | - | - | 15 | - | - | - | 0 | 0 | ||||||
| Taxes Payable Current And Noncurrent | - | - | - | - | - | - | 1 | 1 | 1 | 80 | 81 | 81 | ||||||
| Liability For Uncertain Tax Positions Noncurrent | 572 | 555 | 503 | 443 | 422 | 403 | 385 | 346 | 343 | 337 | 335 | 312 | ||||||
| Litigation Reserve Noncurrent | - | - | 0 | - | - | - | 53 | 64 | 75 | 82 | 94 | 104 | ||||||
| Other Liabilities Noncurrent | 382 | 351 | 362 | 363 | 379 | 358 | 373 | 323 | 257 | 267 | 251 | 240 | ||||||
| Liabilities Of Disposal Group Including Discontinued Operation Noncurrent | - | - | - | 0 | - | - | 0 | 0 | 30 | - | 25 | - | ||||||
| Liabilities | 3,142 | 2,994 | 3,360 | 3,067 | 2,882 | 2,831 | 2,992 | 3,360 | 2,595 | 2,550 | 2,644 | 2,644 | ||||||
Stockholders Equity Including Portion Attributable To Noncontrolling Interest | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 662 | 660 | 659 | 658 | 658 | 656 | 655 | 654 | 654 | 652 | 651 | 650 | ||||||
| Additional Paid In Capital Common Stock | 2,976 | 2,782 | 2,768 | 2,697 | 2,750 | 2,653 | 2,613 | 2,452 | 2,476 | 2,380 | 2,274 | 2,211 | ||||||
| Retained Earnings Accumulated Deficit | 14,863 | 14,621 | 14,241 | 14,149 | 13,858 | 13,525 | 13,167 | 12,781 | 9,711 | 9,344 | 8,992 | 8,623 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -215 | -221 | -238 | -250 | -264 | -255 | -245 | -253 | -220 | -233 | -243 | -250 | ||||||
| Treasury Stock Common Value | -7,668 | -7,514 | -7,092 | -7,050 | -6,456 | -6,451 | -6,192 | -6,090 | -5,183 | -5,025 | -5,025 | -4,576 | ||||||
| Stockholders Equity | 10,618 | 10,328 | 10,338 | 10,205 | 10,607 | 10,192 | 10,063 | 9,546 | 7,505 | 7,118 | 6,650 | 6,658 | ||||||
| Minority Interest | 107 | - | 0 | 0 | 61 | 63 | 65 | 66 | 67 | 69 | 69 | 70 | ||||||
| Liabilities And Stockholders Equity | 13,867 | 13,321 | 13,697 | 13,272 | 13,489 | 13,022 | 13,055 | 12,971 | 10,099 | 9,736 | 9,363 | 9,371 | ||||||
| Allowance For Doubtful Accounts Receivable Current | 16 | 16 | 15 | 13 | 13 | 13 | 12 | 13 | 14 | 14 | 8 | 8 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Preferred Stock Shares Authorized | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | ||||||
| Common Stock Shares Authorized | 1,050 | 1,050 | 1,050 | 1,050 | 1,050 | 1,050 | 1,050 | 1,050 | 1,050 | 1,050 | 1,050 | 1,050 | ||||||
| Common Stock Shares Issued | 662 | 660 | 659 | 658 | 658 | 656 | 655 | 654 | 654 | 652 | 651 | 650 | ||||||
| Shares Outstanding | 577 | 577 | 581 | 581 | 588 | 586 | 589 | 590 | 602 | 602 | 601 | 607 | ||||||
| Treasury Stock Common Shares | 85 | 83 | 78 | 78 | 70 | 70 | 66 | 65 | 51 | 49 | 49 | 43 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialEdwards Lifesciences Corp (EW) — SEC Financial Statements & Analysis
Edwards Lifesciences Corp (EW) is a orthopedic, prosthetic & surgical appliances & supplies company, incorporated in DE. Edwards Lifesciences Corp trades on NYSE as: EW. Edwards Lifesciences Corp (EW)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-04. Based on that filing, Edwards Lifesciences Corp carries a market cap of $52.14B, a P/E ratio of 51.80x, a P/B ratio of 4.86x, a P/S ratio of 8.01x, an enterprise value of $49.83B, and an EV/EBITDA multiple of 30.86x. On profitability, it posts a gross margin of 77.84%, an operating margin of 22.25%, a net margin of 15.46%, a Return on Equity (ROE) of 9.44%, a Return on Assets (ROA) of 7.36%, and a Return on Invested Capital (ROIC) of 12.07%. Per share, it reports EPS of $1.75, diluted EPS of $1.74, free cash flow per share of $2.49, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 14.55% year-over-year, net income growth of -75.71% year-over-year, and EPS growth of -75.26% year-over-year. On the balance sheet, it maintains a current ratio of 4.52x, a quick ratio of 3.69x, working capital of $5.31B, a debt-to-equity ratio of 0.29x, a debt ratio of 0.23, an interest coverage ratio of 37.54x, free cash flow of $1.43B (TTM), and net debt of $-2.31B. Figures sourced from SEC EDGAR.
- Market Cap
- $52.14B
- P/E TTM
- 51.80x
- EPS TTM
- $1.75
- P/B TTM
- 4.86x
- ROE TTM
- 9.44%
- ROA TTM
- 7.36%
- Debt To Equity
- 0.29x
- Free Cash Flow TTM
- $1.43B
- Net Revenue TTM Growth 1Y
- 14.55%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Edwards Lifesciences Corp in?
Edwards Lifesciences Corp (EW) operates in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry.
What exchange does EW trade on?
Edwards Lifesciences Corp (EW) trades on the NYSE.
Where is Edwards Lifesciences Corp incorporated?
Edwards Lifesciences Corp is incorporated in DE.
When was Edwards Lifesciences Corp (EW)'s most recent SEC filing?
Edwards Lifesciences Corp (EW)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-04.
What is EW's market cap?
Edwards Lifesciences Corp (EW) has a market capitalization of $52.14B as of 2026-06-30.
What is EW's P/E ratio?
Edwards Lifesciences Corp (EW)'s trailing twelve month P/E ratio is 51.80x as of 2026-06-30.
What is EW's EPS (earnings per share)?
Edwards Lifesciences Corp (EW)'s trailing twelve month EPS is $1.75 as of 2026-06-30.
What is EW's ROE (return on equity)?
Edwards Lifesciences Corp (EW)'s trailing twelve month Return on Equity (ROE) is 9.44% as of 2026-06-30.
What is EW's ROA (return on assets)?
Edwards Lifesciences Corp (EW)'s trailing twelve month Return on Assets (ROA) is 7.36% as of 2026-06-30.
What is EW's ROIC (return on invested capital)?
Edwards Lifesciences Corp (EW)'s trailing twelve month Return on Invested Capital (ROIC) is 12.07% as of 2026-06-30.
What is EW's EV/EBITDA?
Edwards Lifesciences Corp (EW)'s trailing twelve month EV/EBITDA is 30.86x as of 2026-06-30.